"Strategies for prevention of HPV-related cancers"

Kreftregisteret ved FHIs "HPV CANCEL forum" mottar midler fra Norsk Forening for Epidemiologi (NOFE) til å arrangere webinaret "Raskere eliminasjon av HPV-relatert kreftsykdom"

På denne siden vil vi legge ut informasjon om det kommende webinaret "Strategies for prevention of HPV-related cancers". Webinaret er åpent for alle og vil streames, men det vil også være mulig med fysisk deltakelse (begrenset antall plasser). Begge mulighetene krever påmelding (påmelding her)

Dersom du kun ønsker å følge webinaret digitalt vil du i forkant få tilsendt link til stream

Dersom du ønsker å delta fysisk kan du møte opp ved FHI i Lovisenberggata 8 på Lindern. Her vil du ved registrering få utdelt navnskilt og adgang til auditoriet

 

Programmet under oppdateres fortløpende:

 

Registrering

08.30 – 09.00 Front desk - Norwegian institute of Public Health @ Lindern

 

Welcome to seminar: «Strategies for prevention of HPV-related cancers» 

09.00 – 09.40

Introduction: Mari Nygård, leader, Department of Research, Cancer Registry of Norway at National institute of Public Health 

Presentation #1 Strategies for (faster) elimination of HPV related cancers - Matti Lehtinen

 

Sesson 1 - CervixScreen Norway today and future perspectives 

09.40 – 10.40

Presentation #2 CervixScreen Norway in 2024. Changes, innovations, and challenges - Ameli Trope

Presentation #3 The Added Value of Self-Sampling - Bo T. Hansen

Presentation #4 Clinical follow-up algorithms: added value of methylation - Jean-Marc Costanzi

Presentation #5 Understanding data: does one-size screening fit all? - Discussion Severin Langberg & Sandra Klonteig

Presentation #6 THNK - a science based checklist for science communication - Jo Røislien

Questions and summary

 

Break 10.40 - 10.55

 

Session 2 – HPV vaccination in Norway today – how to increase impact?

10.55 – 12.05

Presentation #7 HPV vaccination in Norway in 2024. Can we do more? - Lill Trogstad

Presentation #8 Monitoring HPV-vaccination program: HPV type distribution in general population - Christin Jonassen

Presentation #9 Monitoring HPV-vaccination program: HPV type distribution in cervical precancers and cancers - Therese Bekkevold 

Presentation #10 Impact of multi cohort vaccination– examples from Scandinavia - Ståle Nygård

Presentation #11 Is there and will there be a need for HPV vaccine booster dose? - Thea Falkenthal

Presentation #12 Impact of strategies to accelerate cervical cancer elimination in Norway: A model-based analysis - Kine Pedersen

Questions and summary

 

Lunch 12.05 - 12.30

 

Session 3 – Strategies to prevent non-cervical HPV-related cancers

12.30 - 13.30

Presentation #13 Blood-based biomarkers for early detection of HPV-driven cancer - Hilary Robbins

Presentation #14 HPV and penile cancer – clinical perspectives and future prevention - Christian Arvei Moen

Presentation #15 Therapeutical HPV-related vaccines – a clinical trial - Siri Torhaug

Questions and summary

Break 13.30 - 13.45

 

Session 4 – Preventing cervical cancer: global perspective

13.45 - 14.15

Presentation #16 Global strategies to eliminate cervical cancer - Philip Castle

 

Panel discussion: Strategies for prevention of HPV-related cancers - current and future perspectives

 

14.15 - 14.45

Moderator: Elisabeth Jakobsen

Panelists: Matti Lehtinen, Hilary Robbins, Lill Trogstad, Ameli Trope, Mari Nygård

 

Summary and final word

Mari Nygård, leader, Department of Research, Cancer Registry of Norway at National institute of Public Health